These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8190534)

  • 1. Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets.
    Lisse IM; Aaby P; Knudsen K; Whittle H; Andersen H
    Pediatr Infect Dis J; 1994 Feb; 13(2):109-12. PubMed ID: 8190534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.
    Aaby P; Lisse IM; Whittle H; Knudsen K; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Epidemiol Infect; 1994 Apr; 112(2):413-20. PubMed ID: 8150016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
    Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Whittle H
    Trans R Soc Trop Med Hyg; 1996; 90(3):326-30. PubMed ID: 8758096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate.
    Aaby P; Knudsen K; Whittle H; Lisse IM; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    J Pediatr; 1993 Jun; 122(6):904-8. PubMed ID: 8501567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-titer measles vaccination before 9 months of age and increased female mortality: do we have an explanation?
    Aaby P; Jensen H; Simondon F; Whittle H
    Semin Pediatr Infect Dis; 2003 Jul; 14(3):220-32. PubMed ID: 12913835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire.
    Cutts FT; Nyandu B; Markowitz LE; Forsey T; Zell ER; Othepa O; Wilkins K
    Vaccine; 1994 Nov; 12(14):1311-6. PubMed ID: 7856296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic parameters 2 years after high-titer measles immunization in Peruvian children.
    León ME; Ward B; Kanashiro R; Hernández H; Berry S; Vaisberg A; Escamilla J; Campos M; Bellomo S; Azabache V
    J Infect Dis; 1993 Nov; 168(5):1097-104. PubMed ID: 8228341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for short or long term morbidity after increased titer measles vaccination in Sudan.
    Libman MD; Ibrahim SA; Omer MI; Adlan IA; Bellavance F; Hoskins E; Bertley F; Ward B
    Pediatr Infect Dis J; 2002 Feb; 21(2):112-9. PubMed ID: 11840077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age.
    Jensen TG; Whittle H; Mordhorst CH; Pedersen IR; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Vaccine; 1994 Aug; 12(11):1026-31. PubMed ID: 7975843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of three measles vaccines in Indian children.
    Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
    Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No strong long-term effect of vitamin A supplementation in infancy on CD4 and CD8 T-cell subsets. A community study from Guinea-Bissau, West Africa.
    Benn CS; Lisse IM; Bale C; Michaelsen KF; Olsen J; Hedegaard K; Aaby P
    Ann Trop Paediatr; 2000 Dec; 20(4):259-64. PubMed ID: 11219162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa.
    Aaby P; Ibrahim SA; Libman MD; Jensen H
    Vaccine; 2006 Apr; 24(15):2764-71. PubMed ID: 16457909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines.
    Atabani S; Landucci G; Steward MW; Whittle H; Tilles JG; Forthal DN
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):111-3. PubMed ID: 10618288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines.
    Whittle H; Aaby P; Samb B; Cissé B; Kanteh F; Soumaré M; Jensen H; Bennett J; Simondon F
    Pediatr Infect Dis J; 1999 Jan; 18(1):53-7. PubMed ID: 9951981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.
    Aaby P; Jensen TG; Hansen HL; Kristiansen H; Thårup J; Poulsen A; Sodemann M; Jakobsen M; Knudsen K; Clotilde da Silva M
    Lancet; 1988 Oct; 2(8615):809-11. PubMed ID: 2902263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.